NCT03431246View on ClinicalTrials.gov

Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9

PHASE3CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

November 5, 2016

Study Completion Date

December 5, 2016

Conditions
Human Papillomavirus Vaccines
Interventions
BIOLOGICAL

Gardasil and Gardasil-9

All subjects will receive one dose of Gardasil-9. Blodd samples for serological testing will be collected just before and one month post Gardasil-9 administration.

Trial Locations (1)

G1E7G9

Laval University Research Hospital Center, Québec

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

lead

Laval University

OTHER

NCT03431246 - Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9 | Biotech Hunter | Biotech Hunter